e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial

Am J Respir Crit Care Med. 2024 May 1;209(9):1168-1169. doi: 10.1164/rccm.202312-2274LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Biomarkers* / blood
  • Disease Progression*
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis* / diagnostic imaging
  • Lung / diagnostic imaging
  • Lung / pathology
  • Male
  • Middle Aged
  • Tomography, X-Ray Computed* / methods

Substances

  • Biomarkers